Human Genome Epidemiology Literature Finder
Records 1 - 4 (of 4 Records) |
Query Trace: Epilepsy and SOD2[original query] |
---|
Superoxide dismutase 2 Val16Ala polymorphism is a risk factor for the valproic acid-related elevation of serum aminotransferases. Epilepsy research 2011 Nov . Saruwatari J, Deguchi M, Yoshimori Y, Noai M, Yoshida S, Ogusu N, Oniki K, Yoshida S, Yasui-Furukori N, Kaneko S, Ishitsu T, Nakagawa K |
Impact of the superoxide dismutase 2 Val16Ala polymorphism on the relationship between valproic acid exposure and elevation of ?-glutamyltransferase in patients with epilepsy: a population pharmacokinetic-pharmacodynamic analysis. PloS one 2014 9 (11): e111066. Ogusu Naoki, Saruwatari Junji, Nakashima Hiroo, Noai Madoka, Nishimura Miki, Deguchi Mariko, Oniki Kentaro, Yasui-Furukori Norio, Kaneko Sunao, Ishitsu Takateru, Nakagaswa Kazu |
The association between antioxidant enzyme polymorphisms and cerebral palsy after perinatal hypoxic-ischaemic encephalopathy. European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 2016 Jun . Esih Katarina, Gori?ar Katja, Dolžan Vita, Rener-Primec Zvon |
Antioxidant polymorphisms do not influence the risk of epilepsy or its drug resistance after neonatal hypoxic-ischemic brain injury. Seizure 2017 Feb 46 38-42. Esih Katarina, Gori?ar Katja, Dolžan Vita, Rener-Primec Zvon |
- Page last reviewed:Feb 1, 2024
- Content source: